Skip to content

Neogen NEOG Total debt

Total debt at other companies

Revvity logo
RevvityRVTY
$3.94B+17.8%
TEC
Bio-TechneTECH
$290.32M-31.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Zoetis logo
ZoetisZTS
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's total debt?
Neogen (NEOG) reported total debt of $793.3M in Q4 2025.
How has Neogen's total debt changed year-over-year?
Neogen's total debt decreased by 11.2% year-over-year, from $893.11M to $793.3M.
What is the long-term trend for Neogen's total debt?
Over 4 years (2021 to 2025), Neogen's total debt has grown at a 337.7% compound annual growth rate (CAGR), from $2.49M to $915.03M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.